Loading…

Sleeping Beauty Insertional Mutagenesis in Mice Identifies Drivers of Steatosis-Associated Hepatic Tumors

Hepatic steatosis is a strong risk factor for the development of hepatocellular carcinoma (HCC), yet little is known about the molecular pathology associated with this factor. In this study, we performed a forward genetic screen using (SB) transposon insertional mutagenesis in mice treated to induce...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 2017-12, Vol.77 (23), p.6576-6588
Main Authors: Tschida, Barbara R, Temiz, Nuri A, Kuka, Timothy P, Lee, Lindsey A, Riordan, Jesse D, Tierrablanca, Carlos A, Hullsiek, Robert, Wagner, Sandra, Hudson, Wendy A, Linden, Michael A, Amin, Khalid, Beckmann, Pauline J, Heuer, Rachel A, Sarver, Aaron L, Yang, Ju Dong, Roberts, Lewis R, Nadeau, Joseph H, Dupuy, Adam J, Keng, Vincent W, Largaespada, David A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hepatic steatosis is a strong risk factor for the development of hepatocellular carcinoma (HCC), yet little is known about the molecular pathology associated with this factor. In this study, we performed a forward genetic screen using (SB) transposon insertional mutagenesis in mice treated to induce hepatic steatosis and compared the results to human HCC data. In humans, we determined that steatosis increased the proportion of female HCC patients, a pattern also reflected in mice. Our genetic screen identified 203 candidate steatosis-associated HCC genes, many of which are altered in human HCC and are members of established HCC-driving signaling pathways. The protein kinase A/cyclic AMP signaling pathway was altered frequently in mouse and human steatosis-associated HCC. We found that activated PKA expression drove steatosis-specific liver tumorigenesis in a mouse model. Another candidate HCC driver, the -acetyltransferase , which we found to be overexpressed in human steatosis-associated HCC and associated with decreased survival in human HCC, also drove liver tumorigenesis in a steatotic mouse model. This study identifies genes and pathways promoting HCC that may represent novel targets for prevention and treatment in the context of hepatic steatosis, an area of rapidly growing clinical significance. .
ISSN:0008-5472
1538-7445
DOI:10.1158/0008-5472.can-17-2281